Results of ECHO study EHA

Graham Collins, Associate Professor of Haematology and lymphoma specialist at Oxford Cancer and Haematology centre, shared on X/Twitter:

“Wang – Echo study EHA2024
– BR v Acala-BR in 1L Mantle,65 years and older
– randomised, double blind, placebo-controlled
– Clear PFS benefit: 27% reduction PD / death
– Trend to OS but not stat sig even when COVID deaths removed
– low cardiac events, slightly more infections.
New SOC?”

Source: Graham Collins/X